Obtenez une réponse de cet employeur
Votre CV et votre lettre de motivation, adaptés exactement à ce que l’employeur recherche.
TRESP and Associates is seeking a Medical Sales Representative – Interventional Cardiology to lead a high-potential territory based in Newcastle, covering Newcastle and surrounding regional accounts.
You will work with Interventional Cardiologists and Cath Lab teams, driving adoption of innovative cardiovascular technologies while delivering excellent clinical support and building long-term partnerships. This hybrid role balances in-person and remote account management.
Join a global leader in medical technology, recognised for delivering innovative cardiovascular solutions that improve patient outcomes. The organisation partners closely with healthcare professionals to introduce advanced technologies, provide clinical support, and drive excellence in patient care through innovation, education, and collaboration.
With a strong commitment to investing in its people, the company offers ongoing professional development, supportive leadership, and genuine long-term career opportunities within a collaborative, high-performing commercial team.
Our client is seeking a Medical Sales Representative - Interventional Cardiology to take ownership of a unique and high-potential territory based in Newcastle.
This hybrid role combines face-to-face account management with strategic remote territory management, allowing you to build strong relationships across key Newcastle hospitals while also managing surrounding regional accounts. Working closely with Interventional Cardiologists and Cath Lab teams, you will play a critical role in driving the adoption of innovative cardiovascular technologies that improve patient outcomes.
The territory has significant untapped potential, making this an exciting opportunity for a commercially minded sales professional who enjoys building relationships, identifying new opportunities and growing business. For the right person, the role also offers future opportunities to expand into additional cardiovascular portfolios as the territory evolves.